Cargando…
Regulation of in vivo behavior of TAT-modified liposome by associated protein corona and avidity to tumor cells
INTRODUCTION: PEGylated liposomes are widely used and studied as carriers for chemotherapeutics. While pharmacokinetics of the encapsulated drug is drastically altered resulting in favorable circulation time, improved tumor accumulation, and better manageable or reduced side effects, therapeutic eff...
Autores principales: | Amin, Mohamadreza, Bagheri, Mahsa, Mansourian, Mercedeh, Jaafari, Mahmoud Reza, ten Hagen, Timo LM |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6241867/ https://www.ncbi.nlm.nih.gov/pubmed/30532532 http://dx.doi.org/10.2147/IJN.S170274 |
Ejemplares similares
-
Increased Targeting Area in Tumors by Dual-Ligand Modification of Liposomes with RGD and TAT Peptides
por: Amin, Mohamadreza, et al.
Publicado: (2022) -
Preparation and characterization of different liposomal formulations containing P5 HER2/neu-derived peptide and evaluation of their immunological responses and antitumor effects
por: Shariat, Sheida, et al.
Publicado: (2015) -
Liposomal formulation of Galbanic acid improved therapeutic efficacy of pegylated liposomal Doxorubicin in mouse colon carcinoma
por: Nik, Maryam Ebrahimi, et al.
Publicado: (2019) -
Author Correction: Liposomal formulation of Galbanic acid improved therapeutic efficacy of pegylated liposomal Doxorubicin in mouse colon carcinoma
por: Nik, Maryam Ebrahimi, et al.
Publicado: (2020) -
Liposomal Drug Delivery Systems for Cancer Therapy: The Rotterdam Experience
por: Amin, Mohamadreza, et al.
Publicado: (2022)